Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLG | P54098 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | P2RY2 | P41231 | 8/20 | 0.46 |
| ▸ | P2RY6 | Q15077 | 7/20 | 0.46 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.46 |
| ▸ | POLA1 | P09884 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31448322 | 0.91 | POLB (0.46) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL6141746 | 0.88 | POLG (0.51) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL585724 | 0.87 | POLG (0.51) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL17215886 | 0.87 | POLG (0.51) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL6038233 | 0.86 | POLG (0.50) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL597307 | 0.85 | POLG (0.49) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL10900419 | 0.85 | POLG (0.49) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL27451032 | 0.85 | POLG (0.49) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL5708922 | 0.84 | POLG (0.48) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL29978240 | 0.84 | POLG (0.47) | POLGPOLBP2RY2P2RY6P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112638362-B | Dry powder formulations of messenger RNA | 川斯勒佰尔公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-119451988-B | Anti-B7-H3 antibodies and uses thereof | 乐普创一生物科技（上海）有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-119930823-A | Anti-CCR 8 antibodies and uses thereof | 乐普创一生物科技（上海）有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-119735678-A | Tumor antigen dependent CD40 agonist single domain antibodies | 乐普创一生物科技（上海）有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-119662655-A | Application of RNA molecule and composition thereof in tumor immunotherapy | 武汉厚先生物医药有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-112384523-B | Ribose cationic lipids | 川斯勒佰尔公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-119462954-A | 5T4/CD40 bispecific antibodies | 乐普创一生物科技（上海）有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119451988-A | Anti-B7-H3 antibodies and uses thereof | 乐普创一生物科技（上海）有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-119110732-A | Gene editing for improving joint function | 奥泽生物疗法公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-112533909-B | Vitamin cationic lipids | 川斯勒佰尔公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-115916158-A | Lipid nanoparticle formulations for mRNA delivery | 翻译生物公司 | 2023-04-04 | — | — | CN | disclosed |
| EP-4110296-A1 | IMPROVED PROCESSES OF PREPARING MRNA-LOADED LIPID NANOPARTICLES | Translate Bio, Inc. (US) | 2023-01-04 | — | — | EP | disclosed |
| CN-115515559-A | Rectal delivery of messenger RNA | 翻译生物公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-115461042-A | Improved method for preparing MRNA-loaded lipid nanoparticles | 翻译生物公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-115443338-A | Methods and compositions for messenger RNA purification | 翻译生物公司 | 2022-12-06 | — | — | CN | disclosed |
| CN-115427021-A | Improved method for preparing MRNA-loaded lipid nanoparticles | 翻译生物公司 | 2022-12-02 | — | — | CN | disclosed |
| CN-106795142-B | Stereochemically enriched compositions for delivery of nucleic acids | 川斯勒佰尔公司 | 2022-11-04 | — | — | CN | disclosed |
| CN-109072223-B | Multimeric coding nucleic acids and uses thereof | 川斯勒佰尔公司 | 2022-10-21 | — | — | CN | disclosed |
| WO-2022081544-A1 | IMPROVED PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES | TRANSLATE BIO, INC. (US) | 2022-04-21 | — | — | WO | disclosed |
| WO-2022081548-A1 | IMPROVED PROCESS OF PREPARING ICE-BASED LIPID NANOPARTICLES | TRANSLATE BIO, INC. (US) | 2022-04-21 | — | — | WO | disclosed |